Abstract:Introduction: Structure-based drug design is a wide area of identification of selective inhibitors of a target of interest. From the time of the availability of three dimensional structure of the drug targets, mostly the proteins, many computational methods had emerged to address the challenges associated with drug design process. Particularly, drug-likeness, druggability of the target protein, specificity, off-target binding, etc., are the important factors to determine the efficacy of new chemical inhibitors. Objective: The aim of the present research was to improve the drug design strategies in field of design of novel inhibitors with respect to specific target protein in disease pathology. Recent statistical machine learning methods applied for structural and chemical data analysis had been elaborated in current drug design field. Methods: As the size of the biological data shows a continuous growth, new computational algorithms and analytical methods are being developed with different objectives. It covers a wide area, from protein structure prediction to drug toxicity prediction. Moreover, the computational methods are available to analyze the structural data of varying types and sizes of which, most of the semi-empirical force field and quantum mechanics based molecular modeling methods showed a proven accuracy towards analysing small structural data sets while statistics based methods such as machine learning, QSAR and other specific data analytics methods are robust for large scale data analysis. Results: In this present study, the background has been reviewed for new drug lead development with respect specific drug targets of interest. Overall approach of both the extreme methods were also used to demonstrate with the plausible outcome. Conclusion: In this chapter, we focus on the recent developments in the structure-based drug design using advanced molecular modeling techniques in conjunction with machine learning and other data analytics methods. Natural products based drug discovery is also discussed.

Landscape of In Silico Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery

Advances in covalent drug discovery

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Integrated Covalent Drug Design Workflow Using Site Identification by Ligand Competitive Saturation

Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices

Covalent Inhibition in Drug Discovery

Extended Applications of Small-Molecule Covalent Inhibitors toward Novel Therapeutic Targets

A Review on Computational Software Tools for Drug Design and Discovery

Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions

Recent Trends in Drug Design and Discovery

Covalent Binding Design Strategy: A Prospective Method for Discovery of Potent Targeted Anticancer Agents.

Molecular Docking and Structure-Based Drug Design Strategies

Chemical Proteomics-based Target Prioritization through a Residue Agnostic Ligandability Assessment Platform

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

Molecular docking as a popular tool in drug design, an in silico travel

Integrated Molecular Modeling and Machine Learning for Drug Design

A Guide to In Silico Drug Design

The Emergence of In-Silico Models in Drug Target Interaction System: A Comprehensive Review

Emerging Landscape of Computational Modeling in Pharmaceutical Development

Sculpting Molecules in Silico: A Comprehensive Review of the Latest Innovations in Computer-Aided Drug Design to Revolutionize the Way Drugs are Engineered and Optimized

Constructing Innovative Covalent and Noncovalent Compound Libraries: Insights from 3D Protein–Ligand Interactions